| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10K | — | -90.9% |
| Cost of Revenue | $391K | — | -24.1% |
| Gross Profit | $1.0M | — | -47.6% |
| R&D Expense | $973K | — | -13.1% |
| SG&A Expense | $979K | — | +4.2% |
| Operating Income | -$1.3M | — | -29.2% |
| Net Income | -$1.0M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.6M | -18.6% | +293.4% |
| Accounts Receivable | $657K | -21.8% | -24.6% |
| Current Assets | $7.3M | -10.3% | +114.2% |
| Total Assets | $18.3M | -4.8% | +21.0% |
| Current Liabilities | $2.2M | -6.1% | -46.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | -203.6% |
| Capital Expenditures | $8K | — | -14.5% |
| Investing Cash Flow | -$8K | — | +14.5% |
| Financing Cash Flow | $28K | — | — |
| Free Cash Flow | -$1.3M | — | -198.8% |
| -1.9% |
| EPS (Basic) | -$0.05 | — | +16.7% |
| EPS (Diluted) | -$0.05 | — | +16.7% |
| $2.2M |
| -6.2% |
| -48.6% |
| Stockholders' Equity | $16.2M | -4.6% | +48.3% |